(redirected from Aminoquinoline)
Also found in: Medical, Wikipedia.
Category filter:
AQAdventure Quest (online game)
AQAir Quality
AQl'Aquila (Italy)
AQAdvanced Queuing (trademark of Oracle)
AQAntarctica (top level domain name)
AQAmerican Samoa
AQAnthraquinone (chemical compound)
AQAquinas College
AQAl-Qaida (terrorist group)
AQAqua (blue-green color)
AQAhn'qiraj (gaming instance, World of Warcraft)
AQAloha Airlines
AQAutomatic Qualifying (sports)
AQAnnual Quantity (UK; gas production)
AQAmerican Quarterly (American Studies Association Journal)
AQAphasia Quotient (language impairment measurement)
AQAssurance Qualité (French: Quality Assurance)
AQAs Quoted (market price)
AQAccomplishment Quotient (measurement)
AQAminoquinoline (chemistry)
AQAction Quake (gaming team)
AQAircraft Quality (steel)
AQAlliance Quebec (Canadian English Rights Lobby Group)
AQAchievement Quotient
AQApplication Question
AQAnnual Questionnaire
AQArchitectural Quality
AQAcoustic Quantification
AQAccumulator-Quotient Register
AQAcquisitions Directorate (USAF)
AQAccess Queue
AQAllowance Quantity
AQ(USN Rating) Aviation Fire Control Technician
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Kirkan, Synthesis and Spectroscopic Properties of New Azo-Dyes and Azo-Metal Complexes derived from Barbituric Acid and Aminoquinoline, Dyes.Pigm, 73, 40 (2007).
(23.) Li, X-G, Huang, M-R, Hua, Y-M, Zhu, M-F, Qunchen, J, "Facile Synthesis of Oxidative Copolymers from Aminoquinoline and Anisidine." Polymer.
falciparum multidrug resistance-1 copy number is also believed to reduce parasite sensitivity to some quinoline antimalarials (typically an aminoquinoline) the partner drug of ACT (17-18).
Chloroquine is a synthetic aminoquinoline and is widely used in the treatment of malaria [1] and also as a prophylactic drug in the prevention of malaria [2].
The safest initial systemic therapy for DM-specific skin disease is single-agent or combined aminoquinoline antimalarial therapy, Dr.
Notable examples include nerve damage among individuals homozygous for some variants of the N-acetyltransferase 2 gene ("slow acetylators") given isoniazid as an antituberculosis therapy, hemolytic anemia among glucose 6-phosphate dehydrogenase-deficient patients given aminoquinoline antimalarial drugs, and varied rates of biotransformation of debrisoquine, an antihypertensive drug, due to genetic variation at the CYP2D6 locus (Weber 1997).
microti genome reveals absence of proteases necessary to digest host hemoglobin and hemozoin formation by the parasite; this absence may explain the ineffectiveness of chloroquine, and perhaps other compounds of the aminoquinoline family used in babesiosis therapy (10).